Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Mountz

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Arthritis and Rheumatism|April 22, 1999
Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptideK R Zinn, T R Chaudhuri, C A Smyth, et al.
Cancer Research|July 15, 1989
Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiographyJ M Mountz, P A Raymond, P E McKeever, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1990
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECTJ M Mountz, J G Modell, N L Foster, et al.
Gene Therapy|September 25, 1998
Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5)K R Zinn, J T Douglas, C A Smyth, et al.
Arthritis and Rheumatism|July 1, 1995
Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levelsJ M Mountz, L A Bradley, J G Modell, et al.
Journal of Immunological Methods|August 23, 2001
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticlesC H Dodd, H C Hsu, W J Chu, et al.
Physics in Medicine and Biology|January 11, 2008
Evaluation of a commercial radiochromatography module as an arterial blood activity monitorC M Laymon, D Sashin, J P Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Arthritis and Rheumatism|April 22, 1999
Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptideK R Zinn, T R Chaudhuri, C A Smyth, et al.
Cancer Research|July 15, 1989
Specific localization of thallium 201 in human high-grade astrocytoma by microautoradiographyJ M Mountz, P A Raymond, P E McKeever, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1990
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECTJ M Mountz, J G Modell, N L Foster, et al.
Gene Therapy|September 25, 1998
Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5)K R Zinn, J T Douglas, C A Smyth, et al.
Arthritis and Rheumatism|July 1, 1995
Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levelsJ M Mountz, L A Bradley, J G Modell, et al.
Journal of Immunological Methods|August 23, 2001
Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticlesC H Dodd, H C Hsu, W J Chu, et al.
Physics in Medicine and Biology|January 11, 2008
Evaluation of a commercial radiochromatography module as an arterial blood activity monitorC M Laymon, D Sashin, J P Carney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomasA Patnaik, L J Appleman, A W Tolcher, et al.
Pageof 7